LAVA Therapeutics's market cap is currently $42.35M. The company's EPS TTM is $-0.32; its P/E ratio is ―; LAVA Therapeutics is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
